Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Clinical Trial Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
... Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others] The clinical trial imaging market size is expected ... Read More
-
Global Neurology Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV) by Study Design (Interventional, Observational, Expanded Access), by Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030
... Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030 Global Neurology Clinical Trials Market is valued at approximately USD 5.24 billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 6 million prevalent cases of PsA in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. There are 14 leading marketed drugs for the treatment of PsA, Janssen is the key player in the ... Read More
-
2023 Global Forecast for Life Science Analytics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Computer Systems Design Services industry. The product or service category is within the NAICS Computer Systems Design Services industry. The global market is expected to ... Read More
-
Lewy Body Dementia (LBD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 1.1 million diagnosed prevalent cases of LBD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. Currently, there are three marketed products for the treatment of LBD. R&D activity within the LBD ... Read More
-
Short Bowel Syndrome (SBS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 94,000 diagnosed prevalent cases of SBS in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. Glucagon-like peptide 2 receptor agonists play a key role in the current treatment paradigm for SBS. R&D activity ... Read More
-
Pharmacovigilance Market - By Type (Software, Service {By Process, By Activity [Spontaneous Reporting, Intensified Adverse Drug Reaction Reporting, Cohort Event Monitoring]}), By Clinical Trial Phase, Service Provider, By End-use, & Forecast, 2023 - 2032
... Pharmacovigilance Market is expected to showcase remarkable growth over 2023-2032, driven by the increasing demand for drug safety monitoring and the need for data-driven insights to ensure patient safety. In addition, increasing demand for new ... Read More
-
Clinical Trial Imaging Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
... the Clinical Trial Imaging market including the COVID-19 pandemic implications for Clinical Trial Imagings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, ... Read More
-
Clinical Trials Management System Market: Current Analysis and Forecast (2022-2030)
... tracking of patient enrolment, scheduling, and visits, as well as the monitoring of study progress and the collection, management, and analysis of trial data. CTMS also helps ensure compliance with regulatory requirements and guidelines, including ... Read More
-
Myelodysplastic Syndrome - Pipeline Insight, 2023
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Myocardial Infarction (MI) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... prevalent cases of MI in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for MI. The marketed drugs space for MI consists of mostly small molecules that are 3 hydroxy 3 methylglutaryl coenzyme ... Read More
-
Global Clinical Trials Market Report and Forecast 2023-2031
... CAGR of 5.40% during the forecast period of 2023-2031 to attain a value of nearly USD 75 billion by 2031. Clinical Trial Market: Introduction Clinical trials are research studies involving human participants, designed to evaluate ... Read More
-
Clinical Trial Imaging Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors Such As Increasing Demand for More Precise ... Read More
-
Clinical Trial Imaging Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors Such As Increasing Demand for More Precise ... Read More
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... total prevalent cases of BDD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. No approved marketed drugs are currently available for the treatment of BDD. R&D activity within the BDD space is ... Read More
-
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... (Hurler Syndrome ) - Global Clinical Trials Review, 2023 provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Review, 2023 provides an overview of Inflammatory Bowel Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Bowel Disease. Report includes an overview of trial numbers and ... Read More
-
Duchenne Muscular Dystrophy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Review, 2023 provides an overview of Duchenne Muscular Dystrophy Clinical trials scenario. This report provides top line data relating to the clinical trials on Duchenne Muscular Dystrophy. Report includes an overview of trial numbers and ... Read More
-
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Review, 2023 provides an overview of Amyotrophic Lateral Sclerosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Amyotrophic Lateral Sclerosis. Report includes an overview of trial numbers and ... Read More
-
Paediatric Clinical Trials Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. High Costs Related to Clinical Studies Likely to ... Read More
-
Paediatric Clinical Trials Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. High Costs Related to Clinical Studies Likely to ... Read More
-
Ankylosing Spondylitis (Bekhterev's Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Clinical Trials Review, 2023 provides an overview of Ankylosing Spondylitis (Bekhterev's Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Ankylosing Spondylitis (Bekhterev's Disease). Report includes an overview ... Read More
-
Spondyloarthritis (Spondyloarthropathy) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... provides an overview of Spondyloarthritis (Spondyloarthropathy) Clinical trials scenario. This report provides top line data relating to the clinical trials on Spondyloarthritis (Spondyloarthropathy). Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Obsessive-Compulsive Disorder Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... provides an overview of Obsessive-Compulsive Disorder Clinical trials scenario. This report provides top line data relating to the clinical trials on Obsessive-Compulsive Disorder. Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Graft Versus Host Disease (GVHD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... - Global Clinical Trials Review, 2023 provides an overview of Graft Versus Host Disease (GVHD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Graft Versus Host Disease (GVHD). ... Read More
Research Assistance
